MedTrace Logo

EMPART - Exercise and Manual Physiotherapy Arthritis Research Trial

NCT00709566 · Status: UNKNOWN · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 150

Last updated 2010-07-23

No results posted yet for this study

Summary

Hip osteoarthritis is a major cause of disability and reduced quality of life. Physiotherapy, which encompasses a range of interventions such as exercise therapy, manual therapy, education and electrophysical agents, is a core component of management. To date, exercise therapy to date has the greatest evidence of effect . However, this evidence is limited as only a short-term benefit has been identified and improvements in pain and function decline over time. There is some limited evidence for a beneficial effect of manual therapy over exercise. However, clinically these interventions are used in combination, not in isolation. To date, no research has investigated the combined effect of exercise and manual therapy in hip OA.

A multi-centre randomised controlled trial that compares the clinical effectiveness of a combination of manual therapy and exercise to exercise therapy only will be conducted.

Conditions

  • Hip Osteoarthritis

Interventions

BEHAVIORAL

Exercise therapy

Participants will attend an exercise based programme once a week for 8 weeks. This will be supplemented by a home based exercise programme.

BEHAVIORAL

Combined exercise and manual therapy

Patients will attend physiotherapy once a week for 8 weeks, where they will receive a combination of exercise therapy and manual therapy. Exercise will be supplemented by a home based exercise programme

Sponsors & Collaborators

  • Royal College of Surgeons, Ireland

    lead OTHER

Principal Investigators

  • Geraldine McCarthy, MD, FRCPI · Royal College of Surgeons in Ireland

  • Tara Cusack, PhD · University College Dublin, Ireland

  • Helen French, MSc · Royal College of Surgeons in Ireland

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
40 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-04-30
Primary Completion
2010-09-30
Completion
2010-12-31

Countries

  • Ireland

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00709566 on ClinicalTrials.gov